These medications help: Slow stomach emptying, leading to increased feelings of fullness Reduce appetite and food intake by acting on brain centers that control hunger Improve insulin secretion and sensitivity Lower blood sugar levels, especially after meals Promote weight loss through multiple mechanisms Mounjaro (tirzepatide) is actually a dual GIP/GLP-1 receptor agonist, meaning it acts on two hormonal pathways related to blood sugar control and appetite regulation, which may explain its particularly strong effects on weight loss
The FDA officially approved Zepbound for chronic weight management in late 2023
It also helps control blood sugar by helping the body make more insulin and reducing how much sugar the liver makes
Continuing to use compromised medication not only wastes money but could introduce bacterial contamination or reduce therapeutic benefit
Kim KH, Lee MS, Choi TY, Kim TH (2018) Acupuncture for symptomatic gastroparesis
Anorexigenic postprandial responses of PYY and GLP1 to slow ice cream consumption: preservation in obese adolescents, but not in obese adults
